Journal of Neural Transmission

, Volume 113, Issue 9, pp 1177–1190

Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome

  • S. Hesse
  • C. Oehlwein
  • H. Barthel
  • J. Schwarz
  • D. Polster
  • A. Wagner
  • O. Sabri
Article

DOI: 10.1007/s00702-005-0401-6

Cite this article as:
Hesse, S., Oehlwein, C., Barthel, H. et al. J Neural Transm (2006) 113: 1177. doi:10.1007/s00702-005-0401-6

Summary.

Single-photon emission computed tomography (SPECT) markers allow measuring the integrity of the brain dopaminergic system in vivo. We used dopamine transporter (DAT) SPECT with [123I]FP-CIT and dopamine D2/D3 receptor SPECT with [123I]IBZM to evaluate whether there is a reduction of DAT and/or D2/D3 receptor SPECT in treated and untreated patients with Parkinsonian syndrome (PS). We found that almost a quarter of our patients treated with anti-Parkinsonian medication prior to SPECT imaging did not show evidence of a presynaptic dopaminergic deficit while 37% of untreated patients were diagnosed as having Parkinson’s disease. 17% of treated patients had additional loss of D2/D3 receptor binding capacity in concordance with the clinical follow-up diagnoses of multiple system atrophy, progressive nuclear palsy, and vascular Parkinsonism. Apart from 38% clinically uncertain cases, SPECT was in concordance with 75% of initial clinical diagnoses. 25% were reclassified as indicated by SPECT findings and confirmed by a 1.5-year clinical follow-up. We conclude that dopamine SPECT may support establishing or refuting the clinical diagnosis and, therefore, help to make the decision for or against dopaminomimetic treatment in cases with PS.

Keywords: Parkinson’s disease, SPECT, dopamine, [123I]FP-CIT, [123I]IBZM. 

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • S. Hesse
    • 1
  • C. Oehlwein
    • 2
  • H. Barthel
    • 1
  • J. Schwarz
    • 3
  • D. Polster
    • 1
  • A. Wagner
    • 3
  • O. Sabri
    • 1
  1. 1.Clinic for Nuclear Medicine, University HospitalLeipzigGermany
  2. 2.Specialized Outpatient’s Centre for Parkinson’s DiseaseGeraGermany
  3. 3.Clinic for Neurology, University HospitalLeipzigGermany

Personalised recommendations